Big Pharma

Analysis and Comment (19)

Kvvmgh99-1351573993
Pathology service providers should be encouraged to adopt a code of conduct similar to that of Medicines Australia. Waiting room image from shutterstock.com

Small step for transparency in medicine but what about pathology?

You’ve probably given little thought to the slip of paper your GP hands you when she sends you off for a blood test. After all, you’re likely to have more important things to worry about. But the next…
Zppvgfkv-1345703802
Pharmaceutical companies undertake clinical trials to determine whether a potential new drug meets the requirements for market authorisation. Chain of figures photo from www.shutterstock.com

How to get drug companies to put needs before profits

New medicines must be approved as safe, efficacious and of good quality before they can be prescribed. But authors of two recent articles in the British Medical Journal argue that governments should introduce…
4py6qb84-1338790154
Drug prices reduce dramatically when large multinationals’ monopoly is broken. m.p.3./Flickr

Big Pharma in legal battles for monopoly prices in India

Two large multinational pharmaceutical companies are fighting for patents and monopoly pricing in Indian courts. The outcomes of the cases – involving Novartis and Bayer – are likely to determine the country…
276q2hz6-1333510226
SKB knew eight adolescents self-harmed or reported emergent suicidal ideas compared to only one in the placebo group but hid this. Michael Valli

Insight into how pharma manipulates research evidence: a case study

TRANSPARENCY AND MEDICINE – A series examining issues from ethics to the evidence in evidence-based medicine, the influence of medical journals to the role of Big Pharma in our present and future health…
Z4jjcpqn-1330407732
If there are legitimate reasons for drug companies to gift doctors, then it should be disclosed. Steven Depolo/Flickr

Gifts that keep on giving: pharma should disclose all links to doctors

How would you feel if your local GP or specialist was pocketing money from a drug company to promote its products? If your gut tells you that this falls squarely into the category of Very Bad Ideas then…
7tvkfq3r-1329197274
Pharmaceutical companies are working in partnership with academia to bring drug candidates to clinical development. Spark/Flickr

New drug buddies: pharma turns to academia for medicines pipeline

The 2008 global financial crisis and an impending “patent cliff” have had a profound impact on the profitability of the pharmaceutical industry – they have made it change how it works. So, to maintain…
7cmmgpfz-1328852510
Repositioning a drug affords pharmaceutical companies the opportunity to enhance the return on their initial investment. bitzi/flickr

Teaching old drugs new tricks: why companies reposition medicines

Many pharmaceutical companies are having to re-examine their product portfolio because of the difficult economic climate. New uses for established drugs affords a way for these companies to maximise financial…
Rgcspjtf-1327903620
The increasing trend of outsourcing drug production is leading to shortages in cancer drugs. Flickr

Risky business: the human cost of outsourcing drug production

It’s the pharmaceutical industry equivalent of the butterfly effect: a drug manufacturing plant in Ohio shuts down production after regulators on two continents uncover contamination problems. Suddenly…
4825051772_5205c60302_b
Vioxx was withdrawn from the Australian market in October 2004 and there’s an ongoing compensation case. DaGoaty/Flickr

Vioxx withdrawal: making sense of the fight for compensation in Australia

The enormous medical impact of modern pharmaceuticals has on occasion been matched by some large-scale litigation regarding adverse events. The Vioxx litigation in Australia and elsewhere is one such recent…
3050802125_4df86436a3_b
The Pharmacy Guild has a deal that encourages pharmacists to sign up patients to Pzifer’s support programs. Marcus Q

One wrong foot after another: the ethics of the Pharmacy Guild’s deals

First it was the Pharmacy Guild’s deal with Blackmores that raised ethical concerns. Now it’s the Guild and Pfizer. Both deals involve undisclosed payments from drug companies to Guild subsidiaries to…
Merck
Pharmaceuticals giant Merck has maintained a low-profile, despite a series of major law suits. AAP

The most powerful companies you’ve never heard of: Merck

Welcome to “The most powerful companies you’ve never heard of” – an ongoing series from The Conversation that sheds light on big companies with low profiles. Today, Deakin University’s Philip Soos examines…
Harsh_vardhan
They may have the same active ingredient, but fillers, colours and lubricants may vary. Flickr/Harsh Vardhan

Explainer: how do generic medicines compare with brand leaders?

“Would you like the generic brand of that medicine?” It’s a question you’ve probably been asked, or at least heard, when picking up a prescription at your local pharmacy. It’s likely you were told the…
Assorted_pharmaceuticals_by_ladyofprocrastination
Uncertainty about how drugs will be listed on the PBS has patient groups, health professionals and the pharmaceutical industry worried. LadyofProcrastination/Wikimedia Commons

New PBS listing rule spooks pharma, doctors and patients

Any parent who watches kids' weekend footy knows that if the ref misses a breach of the rules, merry hell breaks loose. But referees are human and sometimes make errors. We forgive the odd one pretty…
Insectoperfecto_flickr
A test case is slated to challenge Myriad’s claim for breast cancer genetic mutations next February. TheAlieness GiselaGiardino²³/Flickr

Patent controversy: don’t let breast cancer gene genie out of the bottle

The US Court of Appeals for the Federal Circuit has found Myriad Genetics is entitled to patents on two sets human genetic mutations used to predict if women have an increased risk of breast and ovarian…

Research and News (1)

Participants (45)